COMPARE · Reviewed August 3, 2026
ADUS vs FMS
Verdict: Side-by-side breakdown using the Bull Rankings model. ADUS scored 75.1, FMS scored 72.1 — ADUS leads.
Compare another set
Different reporting periods. ADUS's fundamentals are as of March 2026, but FMS's are as of December 2016 — a 113-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
ADUS
Addus HomeCare Corporation
75.1
$116.79 · $2.2B
fundamentals as of
Score gap
3.0
ADUS leads
FMS
Fresenius Medical Care AG
72.1
$25.26 · $13.6B
fundamentals as of
The model, pillar by pillar (0–100 each)
ADUS
stronger →← stronger
FMS
57
Qualityreturns · margins · balance sheet
75
96
Growthrevenue & earnings expansion
75
77
Valuevaluation vs sector peers
78
ADUS and FMS split the three pillars evenly.
Fundamentals, head-to-head
ADUS
FMS
$137mC
FCF
$1.1bC+
+19.6%B+
Rev
+5.9%C+
0.12B+
D/E
0.78C+
21.5xB+
P/E
13.4xA-
1.11B+
PEG
0.91B+
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
ADUS
FMS
12% below
Price vs fair valuelower is cheaper
40% below
~2%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-5%/yr
+8%
1-yr DCF upside
+50%
+13%
5-yr DCF upside
+68%
+22%
10-yr DCF upside
+99%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
ADUS
No notable signals flagged.
FMS
Why this score
- Buying back stock
- Foreign reporter (EUR)
The companies
ADUSAddus HomeCare Corporation
Why now
Medical Care Facilities · market cap $2.2b. 6% off the 52-week high of $124.44. Revenue growing +20%, comfortably above the S&P median. 13 sell-side analysts rate this a Buy with a mean 1-yr target of $133.00 (implying +14% upside).
Moat
FCF converts 138% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
FMSFresenius Medical Care AG
Why now
Medical Care Facilities · market cap $13.6b. 9% off the 52-week high of $27.64. PEG 0.91 — paying under fair value for the growth rate. 7 sell-side analysts rate this a Hold with a mean 1-yr target of $25.95 (implying +3% upside).
Moat
Net margin 24% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 12% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.